Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function.

The central nervous system has the second highest concentration of lipids after adipose tissue. Long chain fatty acids, particularly arachidonic acid and docosahexaenoic acid, are integral components of neural membrane phospholipids. Alterations in neural membrane phospholipid components cannot only influence crucial intracellular and intercellular signaling but also alter many membrane physical properties such as fluidity, phase transition temperature, bilayer thickness, and lateral domains. A deficiency of docosahexaenoic acid markedly affects neurotransmission, membrane-bound enzyme and ion channel activities, gene expression, intensity of inflammation, and immunity and synaptic plasticity. Docosahexaenoic acid deficiency is associated with normal aging, Alzheimer disease, hyperactivity, schizophrenia, and peroxisomal disorders. Although the molecular mechanism of docosahexaenoic acid involvement in the disorders remains unknown, the supplementation of docosahexaenoic acid in the diet restores gene expression and modulates neurotransmission. Also, improvements are seen in signal transduction processes associated with behavioral deficits, learning activity, peroxisomal disorders, and psychotic changes in schizophrenia, depression, hyperactivity, stroke, and Alzheimer disease.

[1]  Yong-Fu Xiao,et al.  Polyunsaturated fatty acids modify mouse hippocampal neuronal excitability during excitotoxic or convulsant stimulation , 1999, Brain Research.

[2]  P. Gean,et al.  Cancellation of low-frequency stimulation-induced long-term depression by docosahexaenoic acid in the rat hippocampus , 1998, Neuroscience Letters.

[3]  G. Durand,et al.  Effect of Fish Oil Diet on Fatty Acid Composition of Phospholipids of Brain Membranes and on Kinetic Properties of Na+, K+‐ATPase Isoenzymes of Weaned and Adult Rats , 1994, Journal of neurochemistry.

[4]  N. Matsuki,et al.  Bidirectional actions of docosahexaenoic acid on hippocampal neurotransmissions in vivo , 2000, Brain Research.

[5]  G. Barceló-Coblijn,et al.  Short-term administration of omega 3 fatty acids from fish oil results in increased transthyretin transcription in old rat hippocampus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[6]  D. Jump,et al.  Dietary polyunsaturated fatty acids and regulation of gene transcription , 2002, Current opinion in lipidology.

[7]  D. Bennett,et al.  Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. , 2003, Archives of neurology.

[8]  A. A. Spector,et al.  Docosahexaenoic acid synthesis from n-3 polyunsaturated fatty acids in differentiated rat brain astrocytes. , 2001, Journal of lipid research.

[9]  R. Friedland Fish consumption and the risk of Alzheimer disease: is it time to make dietary recommendations? , 2003, Archives of neurology.

[10]  L. Horrocks,et al.  Plasmalogens, docosahexaenoic acid and neurological disorders. , 2003, Advances in experimental medicine and biology.

[11]  P. Gean,et al.  Docosahexaenoic acid inhibits synaptic transmission and epileptiform activity in the rat hippocampus , 2000, Synapse.

[12]  L. Ang,et al.  Autopsy Samples of Alzheimer's Cortex Show Increased Peroxidation In Vitro , 1990, Journal of neurochemistry.

[13]  S. Nishiyama,et al.  Docosahexaenoic acid (DHA) improves the age-related impairment of the coupling mechanism between neuronal activation and functional cerebral blood flow response: a PET study in conscious monkeys , 2000, Brain Research.

[14]  D. Guilloteau,et al.  Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex , 2000, Neuroscience Letters.

[15]  S. Rapoport,et al.  Evidence for the Involvement of Docosahexaenoic Acid in Cholinergic Stimulated Signal Transduction at the Synapse , 1997, Neurochemical Research.

[16]  G. Durand,et al.  Diet deficient in alpha-linolenic acid alters fatty acid composition and enzymatic properties of Na+, K+-ATPase isoenzymes of brain membranes in the adult rat. , 1999, The Journal of nutritional biochemistry.

[17]  F. Castelló,et al.  Therapeutic effects of docosahexaenoic acid ethyl ester in patients with generalized peroxisomal disorders. , 2000, The American journal of clinical nutrition.

[18]  R. Dyer,et al.  Brain astrocyte synthesis of docosahexaenoic acid from n-3 fatty acids is limited at the elongation of docosapentaenoic acid DOI 10.1194/jlr.M200120-JLR200 , 2002, Journal of Lipid Research.

[19]  R. E. Anderson,et al.  Essential fatty acid deficiency and renewal of rod outer segments in the albino rat. , 1976, Investigative ophthalmology.

[20]  G. Barceló-Coblijn,et al.  Gene expression and molecular composition of phospholipids in rat brain in relation to dietary n-6 to n-3 fatty acid ratio. , 2003, Biochimica et biophysica acta.

[21]  R. Gibson,et al.  Dietary polyunsaturated fatty acids and inflammatory mediator production. , 2000, The American journal of clinical nutrition.

[22]  A. A. Spector,et al.  Polyunsaturated fatty acids increase lipid radical formation induced by oxidant stress in endothelial cells. , 1994, Journal of lipid research.

[23]  N. Akaike,et al.  Facilitatory effect of docosahexaenoic acid on N‐methyl‐D‐aspartate response in pyramidal neurones of rat cerebral cortex. , 1994, The Journal of physiology.

[24]  Y. Ishibashi,et al.  Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats , 2002, Journal of neurochemistry.

[25]  J. Burgess,et al.  Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder. , 2000, The American journal of clinical nutrition.

[26]  K. Michaelsen,et al.  The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. , 2001, Progress in lipid research.

[27]  N. Nishiyama,et al.  Docosahexaenoic acid improves long‐term potentiation attenuated by phospholipase A2 inhibitor in rat hippocampal slices , 2001, British journal of pharmacology.

[28]  L. Jenski,et al.  Cell-cycle arrest in Jurkat leukaemic cells: a possible role for docosahexaenoic acid. , 2003, The Biochemical journal.

[29]  E. Feskens,et al.  Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. , 1997, American journal of epidemiology.

[30]  K. Myhr,et al.  Effect of dietary advice and n‐3 supplementation in newly diagnosed MS patients , 2000, Acta neurologica Scandinavica.

[31]  M. Hossain,et al.  Antioxidative Effects of Docosahexaenoic Acid in the Cerebrum Versus Cerebellum and Brainstem of Aged Hypercholesterolemic Rats , 1999, Journal of neurochemistry.

[32]  L. Horrocks,et al.  Neural membrane phospholipids in alzheimer disease , 1995, Neurochemical Research.

[33]  M. Debray,et al.  Heterogeneous Na+ Sensitivity of Na+,K+‐ATPase Isoenzymes in Whole Brain Membranes , 1993, Journal of neurochemistry.

[34]  G. Billman,et al.  Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[35]  B. Penke,et al.  Neuroprotective effect of developmental docosahexaenoic acid supplement against excitotoxic brain damage in infant rats , 2003, Neuroscience.

[36]  F. Barrantes,et al.  Apoptosis of Retinal Photoreceptors During Development In Vitro: Protective Effect of Docosahexaenoic Acid , 1997, Journal of neurochemistry.

[37]  P. Bougnoux,et al.  n-3 polyunsaturated fatty acids and cancer. , 1999, Current opinion in clinical nutrition and metabolic care.

[38]  S. Rapoport,et al.  Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. , 2001, Journal of lipid research.

[39]  N. Rotstein,et al.  Protective effect of docosahexaenoic acid on oxidative stress-induced apoptosis of retina photoreceptors. , 2003, Investigative ophthalmology & visual science.

[40]  H. Okuyama,et al.  Pathophysiological effects of dietary essential fatty acid balance on neural systems. , 1998, Japanese journal of pharmacology.

[41]  P. Calder,et al.  Polyunsaturated fatty acids, inflammation, and immunity , 2001, Lipids.

[42]  K. Kristensson,et al.  Fatty acid composition of brain phospholipids in aging and in Alzheimer’s disease , 1991, Lipids.

[43]  Song‐Pyo Hong,et al.  Novel Docosanoids Inhibit Brain Ischemia-Reperfusion-mediated Leukocyte Infiltration and Pro-inflammatory Gene Expression* , 2003, Journal of Biological Chemistry.

[44]  T. Hamazaki,et al.  The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study. , 1996, The Journal of clinical investigation.

[45]  D. Guilloteau,et al.  Dietary fish oil affects monoaminergic neurotransmission and behavior in rats. , 1998, The Journal of nutrition.

[46]  M. Peters-Golden,et al.  Translocation of cytosolic phospholipase A2 to the nuclear envelope elicits topographically localized phospholipid hydrolysis. , 1996, The Biochemical journal.

[47]  Hee-Yong Kim,et al.  Inhibition of Neuronal Apoptosis by Docosahexaenoic Acid (22:6n-3) , 2000, The Journal of Biological Chemistry.

[48]  R. Chandra Health effects of fish and fish oils , 1988 .

[49]  K. Saker,et al.  Polyunsaturated fatty acids and epidermal growth factor receptor/mitogen-activated protein kinase signaling in mammary cancer. , 2001, The Journal of nutrition.

[50]  N. Bazan,et al.  Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[51]  C. Bruehl,et al.  Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[52]  N. Rotstein,et al.  Docosahexaenoic acid promotes differentiation of developing photoreceptors in culture. , 1998, Investigative ophthalmology & visual science.

[53]  J. Infante,et al.  Zellweger syndrome knockout mouse models challenge putative peroxisomal beta-oxidation involvement in docosahexaenoic acid (22:6n-3) biosynthesis. , 2001, Molecular genetics and metabolism.

[54]  H. Sampath,et al.  Polyunsaturated fatty acid regulation of gene expression. , 1998, The Journal of nutrition.

[55]  L. Barrier,et al.  Chronic dietary n-3 polyunsaturated fatty acids deficiency affects the fatty acid composition of plasmenylethanolamine and phosphatidylethanolamine differently in rat frontal cortex, striatum, and cerebellum , 1998, Lipids.

[56]  B. Lejeune,et al.  Age-related changes in phospholipid fatty acid composition and monoaminergic neurotransmission in the hippocampus of rats fed a balanced or an n-3 polyunsaturated fatty acid-deficient diet. , 1997, Journal of lipid research.

[57]  S. Hossain,et al.  Chronic Administration Of Docosahexaenoic Acid Improves The Performance Of Radial Arm Maze Task In Aged Rats , 2001, Clinical and experimental pharmacology & physiology.

[58]  G. Barceló-Coblijn,et al.  Modification by docosahexaenoic acid of age-induced alterations in gene expression and molecular composition of rat brain phospholipids , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[59]  K. Mine,et al.  The chronic administration of docosahexaenoic acid reduces the spatial cognitive deficit following transient forebrain ischemia in rats , 1996, Neuroscience.

[60]  H. Okuyama,et al.  Effect of dietary alpha-linolenate/linoleate balance on brain lipid compositions and learning ability of rats. , 1987, Journal of lipid research.

[61]  S. Innis Essential fatty acids in growth and development. , 1991, Progress in lipid research.

[62]  K. Inoue,et al.  Complete discrimination of docosahexaenoate from arachidonate by 85 kDa cytosolic phospholipase A2 during the hydrolysis of diacyl- and alkenylacylglycerophosphoethanolamine. , 1994, Biochimica et biophysica acta.

[63]  H. Saito,et al.  Dietary Docosahexaenoic Acid Increases Cerebral Acetylcholine Levels and Improves Passive Avoidance Performance in Stroke-Prone Spontaneously Hypertensive Rats , 1997, Pharmacology Biochemistry and Behavior.

[64]  Hee-Yong Kim,et al.  Effect of Docosahexaenoic Acid on the Synthesis of Phosphatidylserine in Rat Brain Microsomes and C6 Glioma Cells , 1998, Journal of neurochemistry.

[65]  M. Hossain,et al.  Influence of docosahexaenoic acid on cerebral lipid peroxide level in aged rats with and without hypercholesterolemia , 1998, Neuroscience Letters.

[66]  M. Minami,et al.  Docosahexaenoic acid attenuated hypertension and vascular dementia in stroke-prone spontaneously hypertensive rats. , 2002, Neurotoxicology and teratology.

[67]  P. Lantos,et al.  Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease. , 1999, Journal of neuropathology and experimental neurology.

[68]  G. Durand,et al.  DHA-enriched phospholipid diets modulate age-related alterations in rat hippocampus , 2003, Neurobiology of Aging.

[69]  J. Gustafsson,et al.  Structural and metabolic requirements for activators of the peroxisome proliferator-activated receptor. , 1993, Biochemical pharmacology.

[70]  D. S. Lin,et al.  Dietary effects on brain fatty acid composition: the reversibility of n-3 fatty acid deficiency and turnover of docosahexaenoic acid in the brain, erythrocytes, and plasma of rhesus monkeys. , 1990, Journal of lipid research.

[71]  J. Pettegrew Molecular Insights into Alzheimer's Disease , 1989, Annals of the New York Academy of Sciences.

[72]  G. Anderson,et al.  The essentiality of n-3 fatty acids for the development and function of the retina and brain. , 1988, Annual review of nutrition.

[73]  I. Issemann,et al.  The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. , 1993, Journal of molecular endocrinology.

[74]  W. Connor,et al.  n-3 fatty acids in the brain and retina: evidence for their essentiality. , 2009, Nutrition reviews.

[75]  R. Holman,et al.  Polyunsaturated fatty acids , 1977 .

[76]  J. Halver,et al.  Docosahexaenoic acid-containing phospholipid molecular species in brains of vertebrates. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[77]  D. Guilloteau,et al.  Polyunsaturated fatty acids and cerebral function: Focus on monoaminergic neurotransmission , 2001, Lipids.

[78]  J. Karanian,et al.  Time- and voltage-dependent block of delayed rectifier potassium channels by docosahexaenoic acid. , 1995, Molecular pharmacology.

[79]  C Chen,et al.  Molecular genetic analysis of synaptic plasticity, activity-dependent neural development, learning, and memory in the mammalian brain. , 1997, Annual review of neuroscience.

[80]  P. Luiten,et al.  Cerebral microvascular pathology in aging and Alzheimer's disease , 2001, Progress in Neurobiology.

[81]  H. Okuyama,et al.  Effect of a high alpha-linolenate and high linoleate diet on membrane-associated enzyme activities in rat brain--modulation of Na+, K+- ATPase activity at suboptimal concentrations of ATP. , 1995, Biological & pharmaceutical bulletin.

[82]  Xianlin Han,et al.  Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry , 2001, Journal of neurochemistry.

[83]  D. Mostofsky,et al.  The role of polyunsaturated fatty acids in restoring the aging neuronal membrane , 2002, Neurobiology of Aging.

[84]  G. Barceló-Coblijn,et al.  The role of n-3 polyunsaturated fatty acids in brain: Modulation of rat brain gene expression by dietary n-3 fatty acids , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[85]  J. Pettegrew,et al.  Brain Membrane Phospholipid Alterations in Alzheimer's Disease , 2001, Neurochemical Research.

[86]  R. Zucker Short-term synaptic plasticity. , 1989 .

[87]  P. Green,et al.  Ethyl docosahexaenoate-associated decrease in fetal brain lipid peroxide production is mediated by activation of prostanoid and nitric oxide pathways. , 2001, Biochimica et biophysica acta.

[88]  M. Akbar,et al.  Protective effects of docosahexaenoic acid in staurosporine‐induced apoptosis: involvement of phosphatidylinositol‐3 kinase pathway , 2002, Journal of neurochemistry.

[89]  M. Lynch,et al.  Age-related changes in synaptic function: analysis of the effect of dietary supplementation with ω-3 fatty acids , 1999, Neuroscience.

[90]  T. Ogawa,et al.  Docosahexaenoic acid reduces GABA response in substantia nigra neuron of rat. , 1996, Journal of neurophysiology.

[91]  Y. Ben-Ari,et al.  Novel form of long-term potentiation produced by a K+channel blocker in the hippocampus , 1991, Nature.

[92]  H. Caffier,et al.  CASA and Ca 125 in diagnosis and follow-up of advanced ovarian cancer. , 1999, Anticancer research.

[93]  Arthur A. Spector,et al.  Astrocytes, Not Neurons, Produce Docosahexaenoic Acid (22:6ω‐3) and Arachidonic Acid (20:4ω‐6) , 1991 .

[94]  N. Hrboticky,et al.  Differential effects of polyunsaturated fatty acids on cell growth and differentiation of premonocytic U937 cells. , 1995, Biochimica et biophysica acta.

[95]  Manuela Martínez Severe deficiency of docosahexaenoic acid in peroxisomal disorders , 1990, Neurology.

[96]  Stanley I. Rapoport,et al.  Membrane Phospholipid Alterations In Alzheimer's Disease: Deficiency of Ethanolamine Plasmalogens , 1997, Neurochemical Research.

[97]  C. Serhan,et al.  Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells , 2003, The Journal of Biological Chemistry.

[98]  M. Kunitomo,et al.  The hypotensive effect of docosahexaenoic acid is associated with the enhanced release of ATP from the caudal artery of aged rats. , 1999, The Journal of nutrition.

[99]  J. Hibbeln,et al.  Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. , 1995, The American journal of clinical nutrition.

[100]  J. Fernstrom Effects of dietary polyunsaturated fatty acids on neuronal function , 1999, Lipids.

[101]  M. Lynch,et al.  Membrane Arachidonic Acid Concentration Correlates with Age and Induction of Long‐term Potentiation in the Dentate Gyrus in the Rat , 1994, The European journal of neuroscience.

[102]  B Attali,et al.  External blockade of the major cardiac delayed-rectifier K+ channel (Kv1.5) by polyunsaturated fatty acids. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[103]  K. Sugioka,et al.  Chronic administration of docosahexaenoic acid improves reference memory-related learning ability in young rats , 1999, Neuroscience.

[104]  M. Lavialle,et al.  Effect of a diet-induced n-3 PUFA depletion on cholinergic parameters in the rat hippocampus Published, JLR Papers in Press, May 16, 2003. DOI 10.1194/jlr.M300079-JLR200 , 2003, Journal of Lipid Research.

[105]  M. Lynch,et al.  The ability of aged rats to sustain long-term potentiation is restored when the age-related decrease in membrane arachidonic acid concentration is reversed , 1997, Neuroscience.

[106]  E. Kishida,et al.  Distinctive inhibitory activity of docosahexaenoic acid against sphingosine-induced apoptosis. , 1998, Biochimica et biophysica acta.

[107]  L. Horrocks,et al.  Health benefits of docosahexaenoic acid (DHA) , 1999, Pharmacological research.

[108]  P. Calder Dietary fatty acids and the immune system. , 2009, Nutrition reviews.

[109]  S. Meydani,et al.  n-3 Polyunsaturated fatty acids and immune function , 1998, Proceedings of the Nutrition Society.

[110]  S. Moore Local synthesis and targeting of essential fatty acids at the cellular interface between blood and brain: a role for cerebral endothelium and astrocytes in the accretion of CNS docosahexaenoic acid. , 1994, World review of nutrition and dietetics.

[111]  D. Guilloteau,et al.  The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids. , 2002, The American journal of clinical nutrition.

[112]  E. Corey,et al.  Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[113]  D. Horrobin,et al.  Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients: comparison with bipolar patients and normal subjects , 1996, Psychiatry Research.

[114]  L. Horrocks,et al.  Plasmalogens, phospholipases A2 and signal transduction , 1995, Brain Research Reviews.

[115]  D. Guilloteau,et al.  Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids. , 2000, Journal of lipid research.

[116]  J. Dyerberg,et al.  The composition of food consumed by Greenland Eskimos. , 2009, Acta medica Scandinavica.

[117]  Thomas E Rohan,et al.  Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormone-related cancers: a review of the epidemiologic evidence. , 2003, The American journal of clinical nutrition.